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Abstract 13 
Inhalation of elevated levels of particulate air pollution has been shown to elicit the onset of adverse 14 
health effects in humans, where the magnitude of the response is a product of where in the lung the 15 
particulate dose is delivered.  At any point in time during inhalation the depositional flux of the 16 
aerosol is a function of the radius of the droplet, thus a detailed understanding of the rate and 17 
magnitude of the mass flux of water to the droplet during inhalation is crucial.  In this study, we 18 
assess the impact of aerosol hygroscopicity on deposited dose through the inclusion of a detailed 19 
treatment of the mass flux of water to account for the dynamics of particle size in a modified version 20 
of the standard International Commission on Radiological Protection (ICRP) whole lung deposition 21 
model.  The ability to account for the role of the relative humidity (RH) of the aerosol prior to, and 22 
during, inhalation on the deposition pattern is explored, and found to have a significant effect on the 23 
deposition pattern.  The model is verified by comparison to previously published measurements, and 24 
used to demonstrate that ambient RH affects where in the lung indoor particulate air pollution is 25 
delivered.   26 
TOC Art 27 
 28 
1.0 Introduction  29 
The association between the inhalation of elevated levels of particulate air pollution and the onset of 30 
local and/or systemic adverse health effects in humans has been well established.1, 2  The severity of 31 
the effect is correlated with the size distribution and chemical composition of the aerosol,3 and overall 32 
exposure.4  Several inhalation models have been used to predict dose,5, 6 typically reporting the 33 
deposited fraction of the total aerosol population within a specific region in the lung as a function of 34 
initial aerosol diameter.  There are numerous challenges in the development of these models that are 35 
both biological,7 such as accounting for variations in lung morphology and breathing patterns, and 36 
physical, such as deposition mechanisms coupled with the fluid dynamics of aerosol transport.8  An 37 
important factor which remains under-evaluated is the role of the chemical composition of the aerosol 38 
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particles in influencing the deposition pattern through influencing hygroscopic growth, and the 39 
influence of the environmental conditions to which the aerosol is exposed prior to inhalation.9, 10 40 
The size of aerosol particles in their surrounding environment is dynamic11 and reliant on the relative 41 
humidity (RH) in the gas-phase of the aerosol (figure 1A).12  The absolute magnitude of the size 42 
change (the capacity for hygroscopic growth) a single droplet can experience as it drifts from one RH 43 
to another is dependent on the chemical composition of the droplet and the two RHs the droplet is 44 
transitioning between.13  The amount of time taken for the aerosol droplet to reach equilibrium with 45 
its surrounding environment, or the rate of change of size, is governed by the kinetics of mass and 46 
heat flux to and from the droplet  surface (figure 1B).14  Thus, a detailed understanding of the 47 
thermodynamic properties and kinetic processes which control the rate and magnitude of mass 48 
transport is required to accurately model aerosol dynamics over the inhalation cycle 49 
An aerosol particle will experience an abrupt change in RH during inhalation when the surrounding 50 
gas-phase water concentration rapidly increases due to the high humidity in the body.  This sudden 51 
change in RH will in turn lead to a rapid increase in the diameter of the particle.15  The RH 52 
experienced by the aerosol particle in the environment external to the body, termed the ambient RH, 53 
affects the size and composition of the aerosol at the point of inhalation, influencing the capacity of 54 
the aerosol to take up further water during inhalation (for example, NaCl in figure 1A).  For instance, 55 
particles of identical dried solute chemical composition suspended in an atmosphere with an RH of 56 
50% (figures 1A and 1C) have greater capacity to absorb water, changing in size by a larger 57 
proportion, than those of an identical initial diameter suspended in an atmosphere with a higher RH 58 
(figure 1D).  Note that the timescale of this size change is dependent on the initial droplet diameter. 59 
Lung models fall into one of two broad categories, either whole lung or local scale.6  Of these, some 60 
are unable to incorporate the hygroscopic condensation that occurs during inhalation16 while others 61 
can,17  clearly illustrating an absence of consensus in the literature of how the hygroscopic behaviour 62 
of inhaled aerosol should be treated.  Although local scale models (typically based on simulations 63 
using computational fluid dynamics (CFD)) produce more accurate predictions of aerosol deposition 64 
within the respiratory tract, validation of these models, in vivo, has been impossible until recently.18, 19  65 
Instead, local scale deposition has been confirmed using in vitro data.20-22  In these studies, a portion 66 
of the upper respiratory tract is constructed (a plastic nose, mouth and/or throat),23 aerosol  introduced, 67 
and then the deposition pattern,24 or total deposition23 measured.  Although highly useful, these in 68 
vitro models are limited to the upper airway and cannot probe in detail the deposition fraction in the 69 
deep lung. 70 
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Though less well defined than CFD models, whole lung models predict regional dose and can be 71 
assessed experimentally.25, 26 The International Commission on Radiological Protection (ICRP) lung 72 
deposition model is considered the standard whole lung model for routine dosimetry assessments.27, 28  73 
A model based on the traditional ICRP model is presented here to demonstrate the importance of an 74 
accurate parameterization of the hygroscopic properties of the aerosol in predicting the total and 75 
regional deposition within the lung and the importance of considering atmospheric conditions when 76 
determining aerosol dosage, and to improve the utility of the traditional ICRP model through an 77 
accurate parameterization of the hygroscopic growth kinetics during inhalation.  Systems in this study 78 
range from simple salts to purely organic aerosol.  The sensitivity of the regional and total dose to the 79 
RH within the lung is also considered.  .     80 
 81 
2.0 Methods 82 
2.1 Model structure 83 
The structure of the inhalation model developed here is that of the ICRP model (figure 2A) described 84 
in detail previously5; sensitivity analysis of the traditional ICRP model has been reported 85 
previously.29-31    Only a brief description of the model will be given, followed by the specific details 86 
of the modifications developed here.  The respiratory tract is divided into five separate regions: nose 87 
(extrathoracic, ET-1), mouth and throat (ET-2), bronchial (BB), bronchiolar (bb) and the alveolar-88 
interstitial (AI) (figure 2A).  During a single breath through the nose, the inhalable aerosol passes 89 
through ET-1, ET-2, BB and bb twice, once during inhalation and once during exhalation, and the AI 90 
only once.  The time taken for each breath and the subsequent time taken for the aerosol to reach each 91 
region during both inhalation and exhalation are calculated based on many factors, including sex, 92 
relative body size and level of activity.  The physical mechanism of particle deposition onto the lung 93 
surface occurs via diffusion and sedimentation (collectively termed thermodynamic deposition), or 94 
impaction (termed aerodynamic deposition).  In each region of the lung, the fraction of all aerosol 95 
removed from the air,  is calculated from: 96 
Eq. 1   = 1 – 𝑒−𝑎𝑟
𝑝
 97 
 a and p are constants, and r is a function of the aerodynamic diameter of the aerosol and the air flow 98 
rate.  The values of a, p and r are unique to each anatomical region and for the mechanism of 99 
deposition.32  A table summarizing the previously reported values of a, p and r is given in Supporting 100 
Information (Table S1).  Both thermodynamic and aerodynamic depositions are highly dependent on 101 
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the size of the particle.  For example, in the AI region of a resting Caucasian male, the aerodynamic 102 
deposition (ae) is:  103 
Eq. 2  ae = 1 – 𝑒(−0.146(2.3𝑑𝑎𝑒
2 )0.6495) 104 
The thermodynamic deposition (th) is: 105 
Eq. 3  th = 1 − 𝑒(−67(2.3𝐷)
0.6101) 106 
dae is the aerodynamic diameter of the particles and D is the diffusion coefficient of the aerosol (which 107 
itself is a function of the particle diameter). Thus it is critical to have a detailed understanding of the 108 
aerosol dynamics during inhalation to accurately predict deposition frequency.  In the standard ICRP 109 
model, the parameterization of hygroscopic growth of the aerosol during inhalation is based on fits to 110 
experimental data33 and is represented by equation 4: 111 
Eq. 4 :  112 
The meaning of these variables is given in Table 1.  A value is selected for dae(∞), typically assumed 113 
to be 3.0 for hygroscopic NaCl droplets.34  Predictions of the time dependent growth of aerosol during 114 
inhalation, using this parameterization for varying values of dae(∞) at the specific time points (where 115 
each time point is when the aerosol is in each region in the lung identified in figure 2A), are shown in 116 
figure 2B.  Parameters such as the ambient RH prior to inhalation were either not considered or 117 
assumed to be inconsequential (Eq. 4).33 118 
2.2 Semi-analytical treatment for hygroscopic growth kinetics of a single particle 119 
In recent work35-38 we have performed detailed measurements of the evaporation of water from 120 
numerous aerosol types to verify the semi-analytical solution to the mass and heat flux equations of 121 
Kulmala et al.39  These continuum regime equations account for the Kelvin effect and incorporate the 122 
transition corrections factors of Fuchs-Sutugin to broaden their predictive potential into the submicron 123 
regime.  The instantaneous mass flux to or from a droplet, I (units g/s), can be calculated from 124 
equation 5: 125 
Eq. 5  I =  126 
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The definition of these variables is given in Table 1.  The method by which this equation is used to 127 
simulate the time-dependence in droplet size has been described in detail in previous publications.35  128 
Physically, Eq. 5 describes the continuum diffusional transport of water between the gas phase at 129 
infinite distance and the droplet surface, and the ensuing condensational (or evaporative) kinetics. 130 
Primarily this mass flux is governed by difference between the water activity within the droplet (and, 131 
thus, the droplet vapour pressure and partial pressure of water at the droplet surface) and the degree of 132 
saturation (the partial pressure of water in the gas phase) at infinite distance. In extreme cases, 133 
transport across the droplet surface may be slowed by other kinetic factors such as the presence of a 134 
surfactant coating (factored in through the transitional correction factor M) or through the slow 135 
diffusion of water within the bulk of the particle (not considered by equation 5).40 Additionally, Eq. 5 136 
accounts for the correction to the mass flux required to correct for the slow heat flux to/from the 137 
particle and the accompanying displacement in droplet temperature away from that of the gas phase. 138 
We use equation 5 to predict the time-dependent growth kinetics of aerosol of varying 139 
composition/hygroscopic response during inhalation. The diameter of the aerosol droplets at 140 
appropriate points in time (indicative of the time reached in each region in the lung, figure 2A) were 141 
extracted and used to refine the predictions from the conventional ICRP framework. Then, the 142 
subsequent deposition fraction was estimated.  Unless otherwise stated, the assumption is made that 143 
the thermal accommodation coefficient is unity; a range of values of the mass accommodation 144 
coefficient are considered (1.0 to 5.0 × 10-5).41  Further, it is assumed that there is no bulk limitation 145 
to mass transfer, i.e. diffusional mixing within the droplet is much more rapid than the timescale of 146 
water transport such that the particles remained homogeneous.14  The water activity in the droplet at a 147 
particular radial growth factor is critical in determining the flux; the association between water 148 
activity and radial growth factor determines the extent (figure 1A) and rate (figure 1B) at which a 149 
given aerosol will grow following inhalation.  For the inorganic aerosols studied here, the radial 150 
growth factor at a corresponding water activity is determined using the Aerosol Diameter Dependent 151 
Model (ADDEM) (Supplemental Figure 1A).42, 43  For the organic aerosol, GF is derived using κ-152 
Kohler theory (Supplemental Figure 1B), according to: 153 
Eq. 6     154 
where  is the dimensionless hygroscopicity parameter.44  For multiple component aerosols, whether 155 
multiple inorganic or organic species (or a mixture of the two), the hygroscopic behaviour of the 156 
aerosol can be readily estimated via the Zdanovskii-Stokes-Robinson (ZSR) approach.45-47  157 
A comparison of the predicted growth kinetics of pure NaCl droplets using both the standard ICRP 158 
hygroscopic response and the semi-analytic kinetic model is shown in figure 2B.  Differences between 159 
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the ICRP treatment using the conventional hygroscopic response and the refined treatment are 160 
apparent, regardless of the RH in which the aerosol is equilibrated or the initial size.  The difference 161 
in this size region greater than 50 µm is largely unimportant as the deposition of aerosols within this 162 
size regime tends to be 100% of the inhalable fraction. 163 
2.3 Conditions of the Model 164 
All parameters used for the model, aside from the specific diameter growth factor/water activity 165 
relationships for the aerosol considered here, have been described in detail previously.32  Unless 166 
otherwise stated, the conditions were those for a healthy Caucasian male breathing through his nose 167 
while doing light exercise with an RH within the lung of 99%.  The RH in the lung of a healthy 168 
individual has been estimated to reach near saturation with an RH between 99% and 99.5%.48, 49  The 169 
simulations from the model developed here are identified in the figures by the ambient RH 170 
immediately prior to inhalation.  The simulations produced using the traditional ICRP model are 171 
identified by the dae(∞) value (Eq. 4). 172 
Note that not all particle growth occurring during inhalation may be steady; rather rapid non-linear 173 
size changes of crystalline aerosol particles are known to occur through deliquescence (e.g. RH of 174 
75% for NaCl) during inhalation.  This would result in inhaled dry NaCl particles undergoing no 175 
growth in the upper airways followed by rapid growth in the deep lung.  To simplify the model, all 176 
aerosol is maintained as a liquid, where the solute concentration ranged from dilute, to saturated, 177 
through to supersaturated (between 50% RH and 75% for NaCl).  Salt particles are only modelled 178 
down to an RH of 50% while organic aerosol are modelled down to RH <20 %.  179 
 180 
3.0 Results 181 
3.1 Validation of model through comparison with experimental data 182 
Two commonly referenced studies that examined the deposition of mono-disperse aerosol in the 183 
respiratory tract were reported by Tu and Knutson,50 and by Blanchard and Willeke.51  The structure 184 
of these studies was as follows: NaCl50, 51 (or kerosene 50) was nebulized, dried, size selected and held 185 
in a Teflon bag.  Immediately prior to inhalation, Tu and Knutson raised the RH of the droplets to 186 
95%, while Blanchard and Willeke left the aerosol dry.  The difference in aerosol counts between the 187 
inhaled and exhaled air was then measured.  The results of their studies are shown in figure 3.   188 
All of the parameters and experimental conditions used by Tu and Knutson, from the generation of the 189 
aerosol, to the pre-treatment and biological factors such as lung volume and sex, are able to be 190 
accounted for in the model developed here and a comparison is shown in figure 3.  Excellent 191 
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agreement was found for both the hygroscopic (NaCl) and hydrophobic (kerosene) aerosols.  Proper 192 
consideration of the pre-treatment of the NaCl aerosol prior to inhalation was essential to accurately 193 
predict the deposition pattern (figure 3A).   194 
The importance of quantifying the hygroscopicity of the aerosol is shown in figure 3B.  Kerosene is a 195 
hydrocarbon liquid consisting of a mixture of carbon chains between 6 and 16 carbon per molecule.  196 
The κ value of a low solubility organic aerosol is ~0.0352 .  Excellent agreement in total dose between 197 
the model and experimental results is observed only if the aerosol is assumed to have low 198 
hygroscopicity with values between 0.05 and 0.01.  This demonstrates that through accurately 199 
simulating the dynamics of organic aerosol growth, accurate predictions of aerosol deposition within 200 
the lung are possible in the ICRP framework. 201 
 202 
3.2 The ambient RH affects the deposition pattern of pure inorganic aerosol 203 
The influence of the RH prior to inhalation on the deposition pattern of NaCl within the lung is shown 204 
in figure 4A.  Of particular interest in this study is how specific changes in the model conditions 205 
affected the deposition pattern.  For ease of comparison between multiple deposition patterns, rather 206 
than reporting multiple full deposition patterns, we report the differences in the deposition fractions 207 
for two different environments.  In doing this, the subtle changes in the deposition pattern become 208 
immediately apparent (figure 4B).  For particles larger than 0.1 µm in diameter, lowering the RH prior 209 
to inhalation was found to lead to a significant increase in lung deposition in every region, with the 210 
largest increases observed in the alveolar-interstitial region and, to a slightly lesser extent, in the 211 
bronchial region.  Deposition in this size regime is governed by aerosol impaction and sedimentation, 212 
suggesting that increasing the magnitude of the size change of particles during inhalation increases the 213 
influence of these deposition mechanisms.  Below 0.1 µm, lowering the RH prior to inhalation has the 214 
opposite effect, slightly lowering the aerosol deposition in the bronchi and alveolar regions.  The 215 
reason for this reduction in deposition fraction is attributed to the increase in aerodynamic diameter 216 
for the aerosol particles following inhalation: the particles become too large to be removed via 217 
diffusion while remaining too small to be removed via sedimentation.   218 
Similar comparisons of the deposition pattern of NaCl aerosols, as predicted by the standard ICRP 219 
model (with dae(∞) = 3) and for NaCl aerosol at an ambient RH of 50% (as predicted by our model) 220 
are shown in figure 4C.  For aerosol larger than 100 nm, a similar deposition pattern was observed for 221 
these two simulations; this was not unexpected given that the ICRP model used with a dae(∞) = 3 is 222 
commonly used to predict total and regional dose of NaCl.   223 
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When the ambient RH is increased to 90% (figure 4D), a more pronounced difference between the 224 
traditional ICRP estimation and the refined model is observed in the deposition pattern.  Below 100 225 
nm, the ICRP underestimates the overall deposition by ~20% due to an overestimation in the 226 
magnitude of water uptake when the surface curvature (or Kelvin effect) is not considered (figure 2B).  227 
The importance of the Kelvin effect in aerosol dynamics is well understood, hence its integration in 228 
numerous lung deposition models.53, 54  The absence of an appreciation of the Kelvin effect in the 229 
standard ICRP model limits its accuracy for predicting aerosol deposition for this size region.  Figure 230 
4D clearly demonstrates the limitations of the standard ICRP model: ambient conditions are not 231 
considered which leads to inaccurate estimations of dose. 232 
Due to the insensitivity of the radial growth dependence of aerosol on RH over the ambient 233 
temperature range 0 – 40 OC, changing the ambient temperature was found to have no effect on the 234 
deposition pattern (data not shown).  235 
The effect of aerosol hygroscopicity on the deposition pattern for aerosol containing similar species 236 
was examined.  NaCl and ammonium sulphate ((NH4)2SO4) both have well-defined deliquescence 237 
(75% for NaCl and 79% for (NH4)2SO4) and efflorescence (45% for NaCl and 37% for (NH4)2SO4) 238 
RHs, but show subtle differences in their radial growth factors when the aerosol is liquid 239 
(Supplemental Figure 1A).  Despite NaCl and (NH4)2SO4 having similar hygroscopic behaviour, a 240 
significant difference in the deposition pattern in the lung was observed in their inhalation simulations 241 
(Supplemental Figure 2); the largest difference, of 14%, between the two deposition patterns was for 242 
aerosol with a diameter around 700 nm. 243 
 244 
3.3 The RH in the lung affects the deposition pattern of pure NaCl aerosol 245 
The RH within the alveolar regions of the lung is considered to be near saturation (~99.5%).55  In the 246 
upper airways, the RH is dependent on many factors including the RH of the inhaled air, breathing 247 
rate and the disease state of the individual.  RH probes are notoriously inaccurate at RH above 90% 248 
with a typical error associated with the probe in excess of ±2%, thus making direct and reliable 249 
measurements of the RH in the upper airway impossible.  The sensitivity of the deposition pattern of 250 
NaCl aerosol to the assumed humidity within the lung is significant (figure 5 and Supporting 251 
Information Figure 3), with upwards of 45% more aerosol ranging in size between 800 to 900 nm 252 
being deposited in the healthy lung that the diseased lung (figure 5A).  253 
 254 
3.4 The physicochemical properties of organic aerosol affect the lung deposition pattern 255 
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Organic aerosols are common to urban environments.  Of interest to this study are the differences in 256 
the deposition pattern in the lung resulting from changes to the physicochemical of the organic aerosol 257 
(figure 6).   258 
A reduction in the hygroscopicity parameter κ (see Eq. 6) leads to significant changes in both the rate 259 
and magnitude of the size change of the aerosol during inhalation across a broad range of initial 260 
diameters (figure 6A).  This difference in size leads to a significant change in the deposition pattern in 261 
the lung (figure 6B and Supporting Figure 4).     262 
Common to organic aerosols is the presence of surface active species that can limit the rate of mass 263 
flux to and from the droplet.  In modelling aerosol mass flux, the likelihood of water uptake is 264 
characterised by the mass accommodation coefficient (α), which is equivalent to the fraction of 265 
molecular collisions of water with the surface that lead to absorption within the aerosol droplet bulk.  266 
For pure water, α is above 0.556 and is reduced as the surface of the droplet becomes covered with 267 
surface active species.35  The sensitivity of the deposition pattern to the mass accommodation 268 
coefficient was explored (figure 6C).  Minimal differences in the deposition pattern were observed 269 
until α was reduced to 5 × 10-4.  For reference, this α value is similar to that for the evaporation 270 
coefficient for water transport across the interface of a drying aerosol droplet coated in 1-271 
pentadecanol (C15H31OH).  272 
 273 
3.5 Estimating regional and total dose of indoor air pollution as a function of relative humidity 274 
Regardless of aerosol type, the majority of fluctuations in regional and total dose as a function of 275 
ambient RH were observed for aerosol between 100 nm and 10 µm.  The sources of indoor particulate 276 
air pollution are limited, resulting in a size regime encapsulated in this region (centred ~1 µm in 277 
diameter57).  Based on the size distribution of indoor particulate air pollution measured by Yang et al. 278 
(Supporting Figure 6),57 the changes in regional and total dose were estimated using the modified 279 
ICRP model (figure 7). 280 
Ambient RH was found to have little effect on the total dose (figure 7D), or the dose delivered to the 281 
exothoracic region (figure 7A).  However, the hygroscopic response was shown to shift significantly 282 
deposition to the alveolar region from the bronchiolar region as the ambient RH increased.   283 
Ambient RH may affect the adverse health effects associated with indoor air pollution (figure 7).  The 284 
location in the lung that the dose is delivered will be affected by ambient RH, which may have a 285 
dramatic effect on the downstream biological response.  The potential for adverse health effects 286 
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associated with these shifts in deposition pattern to result from long term exposure will need to be 287 
explored further. 288 
 289 
4.0 Discussion  290 
A novel adaptation to the traditional ICRP model to incorporate a detailed treatment of the kinetic and 291 
thermodynamic response of the aerosol during inhalation is presented.  The parameters of the model 292 
are presented (Tables 1 and SI1).  This model can readily predict the total and regional dose for any 293 
aerosol where the hygroscopic growth as a function of RH is known; for numerous pure (and 294 
multicomponent) aerosols, there are many aerosol thermodynamic models to predict this behaviour 295 
available online (e.g. the Extended AIM Aerosol Thermodynamics Model). 296 
The condensational growth of a droplet during inhalation is governed both by the hygroscopic 297 
capacity of a droplet to grow (a thermodynamic factor) and the kinetics of mass fluxes.  Although the 298 
largest changes in the deposition pattern results when the capacity for hygroscopic growth is 299 
accurately accounted for, kinetic factors do also play an important role with size changes occurring on 300 
the same timescale as inhalation/exhalation, particularly if precise estimations of regional and total 301 
dose are required (figure 6C). 302 
A common observation seen here is that changes to aerosol growth, whether due to the aerosol 303 
composition or the RH (either in the lung or ambient), affect the deposition fraction in opposing ways 304 
for particles smaller and larger than 100 nm.  For example, consider the effect of RH within the lung 305 
itself on regional dose.  The airway with an RH of 95% (figure 5A) experiences a substantial decrease 306 
in the overall aerosol deposition in the size region between 0.1 and 5 µm when compared to the 307 
healthy lung while at the same time an increase in total aerosol deposition for aerosol under 100 nm 308 
was predicted for the lung with an RH of 95%.  Broadly speaking, limitations to aerosol growth lead 309 
to an increase in the deposition frequency of aerosol under 100 nm, and a decrease in the deposition 310 
frequency of the aerosol between 0.1 and 10 µm.  Thus, the consequences of hygroscopic growth 311 
during inhalation on the deposition pattern is dependent on aerosol size (whether it is above or below 312 
100 nm) and should be treated as such.58 313 
The importance of the hygroscopic behaviour of inhaled aerosol on the deposition pattern may be 314 
amplified for those with diseases of the lung.  For example, asthmatics experience airway constriction 315 
and difficulty breathing in humid conditions, which is believed to be triggered by airway sensory 316 
nerves that are sensitive to temperature changes.59  Additionally, the inhalation of submicron 317 
particulates also triggers similar asthmatic symptoms.60  In section 3.2, aerosol particles under 100 nm 318 
in diameter were shown to deposit to a higher degree when the aerosol growth during inhalation was 319 
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limited at higher ambient RH (figure 4B).  Thus, limitations to aerosol growth during inhalation could 320 
lead to a larger dose of sub 100 nm in diameter aerosol particles penetrating deep into the lung and 321 
may trigger and amplify asthmatic symptoms.   322 
The results of figure 5 may be used to gain insight into both the pathogenesis and treatment of lung 323 
diseases such as asthma and chronic obstructive pulmonary disease (COPD), where both conditions 324 
result from chronic inflammation and are characterized by airway wall thickening.61, 62  The 325 
thickening of the airway wall leads to an overall reduction of the humidity within the afflicted lungs.63  326 
Both the exacerbation and pathogenesis of these conditions have been associated with the inhalation 327 
of particulate air pollution with an aerodynamic diameter under 100 nm.  As shown in figure 7, a 328 
reduction of humidity in the lung leads to an increase in the deposition of aerosols within this size 329 
fraction deep in the lung.  In the treatment of asthma and COPD, the drug is delivered directly to the 330 
lung through the inhalation of a pharmaceutical-containing aerosol.  The aerosols generated from 331 
pharmaceutical delivery devices (e.g. nebulizers) typically have a log-normal particle size distribution 332 
with a mean aerodynamic diameter between 3 and 5 µm.  When compared to the humid lung (RH of 333 
99.9%), the dry lung (RH of 95%) shows a reduction in pharmaceutical aerosol deposition, meaning 334 
the effective dose of these pharmaceutics may be reduced by up to 50%.  There is increasing evidence 335 
that drug deposition into the peripheral lung provides an improved clinical treatment compared to 336 
large aerosol treatment.64  This reduction in dose to the deep lung has the potential to reduce in drug 337 
efficacy; further study is required to explore this further.  It should be noted that airway remodelling 338 
(e.g. gland enlargement, subepithelial fibrosis, epithelial alterations) can be a common feature of some 339 
diseases of the lung, such as emphysema and COPD.65  These modifications (e.g. breakdown of tissue, 340 
mucus-hypersecretion) will clearly have a significant effect on the aerosol deposition rate in the lung 341 
as narrower airways will lead to a higher deposition rate via diffusion (remembering that deposition 342 
via diffusion is a function of aerosol diameter/hygroscopic growth).  An improved understanding of 343 
the interplay between aerosol dynamics and the physical structure of the lung and their combined 344 
influence on deposition rates is critical for studying both the treatment, and pathogenesis, of lung 345 
disease. 346 
Although there is an appreciation of the hygroscopic growth of an aerosol during inhalation on total 347 
and regional dose, what is continually overlooked are the conditions of the aerosol prior to inhalation, 348 
specifically the RH in which it is situated.  An example of this is the article by Mitsakou et al.54 where 349 
they developed a whole lung Eulerian model to predict aerosol deposition.  In the model, aerosol 350 
growth is calculated using the theory described by Mason;66  the humidity in which the aerosol 351 
originates is not considered and the aerosol growth calculated is that of an originally dry aerosol.  This 352 
oversight meant that the aerosol growth in their model may be overestimated, which may explain the 353 
slight (~5-10%) over estimation in the deposition fraction observed when their model was compared 354 
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to experimental data; over estimating aerosol growth leads to an increase in the deposition fraction for 355 
aerosol 0.01 to 1 µm in diameter (figure 4).  The sensitivity to the ambient RH is typically not 356 
considered in lung inhalation models; in the literature review made during the preparation of this 357 
manuscript, no articles discussing this point were found.  We speculate that this oversight is present in 358 
numerous models, and consideration of it should serve to improve other current inhalation models.  359 
 360 
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6.0 Figures 371 
Figure 1 372 
 373 
The (A) relative magnitude and (B) absolute rate of hygroscopic growth of a single inhaled NaCl 374 
aerosol droplet when the ambient RH prior to inhalation is at 55% (green) and 95% (blue); the dry 375 
radius for both particles is 1 µm.  The arrows in (A) show the magnitude of change in radial growth 376 
factor (indicated by the dotted lines) two droplets will experience during inhalation; the droplet 377 
initially suspended in air at RH=55% will grow more than the droplet initially suspended at an 378 
RH=95% during inhalation. The relative growth following inhalation of NaCl aerosols of various 379 
initial diameters that have equilibrated at RHs of (C) 50% and (D) 95%.  380 
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Figure 2 381 
 382 
(A): The structure of the ICRP model (see text for definitions of regions); each anatomical region of 383 
the lung is indicated by shade for both the inset image and circles.   The time point in which the parcel 384 
of air passes through each given region is indicated by number within each circle.  The hygroscopic 385 
growth of aerosols of initial diameters of (B) 50 µm, (C) 5 µm, (D) 0.5 µm and (E) 0.05 µm following 386 
inhalation where the RH within the lung is 99% as predicted by the ICRP model (dae(∞) = 3.0) 387 
(diamonds) and by the semi-analytical solution to the mass and heat flux equations of Kulmala et al 39 388 
(lines) (where the ambient RH was either 50% or 95%).  Note that the time points indicated in the 389 
circles of (A) correspond with those for dae(∞) in (B). 390 
  391 
16 
 
Figure 3 392 
 393 
Comparison of the deposition fraction of (A) NaCl and (B) organic aerosol mimics in the lung 394 
predicted by the model developed here and the traditional ICRP model with the experimental data 395 
collected by Tu & Knutson 50 and Blanchard & Willeke.51  For both (A) and (B), the symbols indicate 396 
previously reported experimental data of human exposure.  For (A), the lines indicate dose predictions 397 
from the traditional ICRP model (d(∞)=3.0 and d(∞)=2.0) and from the adapted ICRP model reported 398 
here (where the ambient RH was either 50% or 95%).  For (B), the lines indicate dose predictions 399 
from only the adapted ICRP model reported here while the hygroscopic behaviour of the aerosol was 400 
estimated by setting the κ-value given into equation 6 (Supplementary Information Figure S-1).   401 
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Figure 4 402 
 403 
(A) Deposition fraction (DF) of NaCl aerosols in the extrathoracic region (Ex), bronchial region (Br), 404 
alveolar-interstitial region (Al) and total lung (Total) as a function of relative humidity (RH) the 405 
aerosol experiences prior to inhalation.  Differences in the DF of inhaled aerosol as a function of the 406 
magnitude of aerosol growth during inhalation are also reported.  Specifically, changes in the DF of 407 
NaCl aerosols resulting from the conditions of the aerosol immediately prior to inhalation are 408 
explored.  (B) is the difference in deposition fraction for NaCl suspended in an ambient air with an 409 
RH of 50% and 95% prior to inhalation.  The difference in deposition fraction between the ICRP 410 
model prediction of hydrophilic aerosol and the prediction for NaCl suspended in an ambient air with 411 
an RH of (C) 50% and (D) 95% prior to inhalation.    412 
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Figure 5 413 
 414 
  415 
Differences in the deposition fraction (DF) of inhaled aerosol (initially at an ambient RH of 50%) 416 
resulting from the changes in RH in the lung as a function of aerosol diameter.  Deposition in a lung 417 
with an RH of 99.9% is compared with deposition in a lung with an RH of (A) 95% and (B) 99%.   418 
Total deposition (Total), combined bronchi and bronchiolar (Br), extrathoracic (nose, mouth and 419 
throat) (Ex), and alveolar-interstitial (Al).    420 
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Figure 6 421 
 422 
 423 
How the growth dynamics of organic aerosol affect total and regional dose.  (A) The growth kinetics 424 
of two organic aerosols of different hydrophobicities in the lung where the ambient RH is 20%.  The 425 
colour of the line indicates the starting diameter of the droplet (black for 5 micrometers, left y-axis. 426 
And grey for 50 micrometers, right axis) while the line style indicates hygroscopicity of the droplet 427 
(i.e. the value of ). (B) How this difference in dynamic behaviour of the aerosol described in (A) will 428 
affect the subsequent deposition fraction (DF) of the aerosol in the lung.  (C) Surface active species 429 
affect the total and regional doses; the deposition pattern of organic aerosol with a mass 430 
accommodation coefficient (α) of 0.00005 is compared to that of water. Total deposition (T), 431 
combined bronchi and bronchiolar (B), extrathoracic (nose, mouth and throat) (Ex), and alveolar-432 
interstitial (Al).    433 
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Figure 7 434 
 435 
The percentage of the total dose of indoor particulate air pollution delivered to the exothoracic region 436 
(A), bronchi region (B), alveolar region (C) and the whole (D) lung as a function of ambient RH and 437 
particle type.  The specific particle types shown consist of a solute of either pure NaCl or an organic 438 
aerosol mimic for which the hygroscopic behaviour is determined by the value of κ (equation 6), with 439 
a value of 0.5 representing a hygroscopic aerosol and a value of 0.05 an aerosol of low hygroscopic 440 
response. Doses were modelled for a male at rest breathing through his mouth.   441 
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7.0 Tables 442 
Table 1: Variables Used in Modified ICRP Model 
Symbol Unit Name and/or Meaning 
dae µm Aerodynamic diameter 
dae(0) µm Aerodynamic diameter at the point of inhalation 
dae(t) µm Aerodynamic diameter at time t 
dae(∞)  Unitless Equilibrium growth value/Relative growth in the lung the 
aerosol will reach given an infinite amount of time 
t  s Time from the point aerosol enters respiratory tract 
I g/s Instantaneous mass fulx to or from a droplet 
a µm Droplet radius 
S∞ Unitless Water saturation ratio in the gas phase of the aerosol 
βm Unitless Transitional correction factors for mass 
βT Unitless Transitional correction factors for temperature 
aw  Unitless Activity of water at the surface of the droplet  
M g/mol Molar mass of water 
Dw cm2/s Diffusion coefficient of water in the gas phase  
pv,∞ Pa Saturation vapour pressure of water 
A  Unitless Stefan flow correction 
K  W/(mK) Thermal conductivity of the gas phase 
R m3PaK-1mol-1 Molar gas constant 
L  J/kg Latent heat of vaporization per unit weight of water 
Sh Unitless Sherwood number/ Accounts for the enhancement of mass flux 
in an airflow 
GF Unitless Radial growth factor 
  Unitless Dimensionless hygroscopicity parameter from κ-Kohler theory  
Sa Unitless Activity at the surface of the droplet 
T∞ K Gas temperature 
D cm2/s Diffusion coefficient of aerosol 
  443 
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